Cannabidiol (CBD) Clinical Trials
4 recruitingDrug
Phase 23Early Phase 11Phase 31
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
Metastatic Colorectal Cancer (CRC)Oxaliplatin Induced Peripheral Neuropathy in Cancer PatientsPeripheral Neuropathy Due to Chemotherapy
Fox Chase Cancer Center30 enrolled1 locationNCT07167446
Recruiting
Phase 2
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
Osteoarthritis, Knee
Steven E Harte, PhD200 enrolled1 locationNCT04992624
Recruiting
Phase 2Phase 3
Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis
NYU Langone Health100 enrolled1 locationNCT05020028
Recruiting
Phase 2
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
PainSleepMultiple Sclerosis
Tiffany J. Braley, MD, MS166 enrolled1 locationNCT05269628